ADC Therapeutics (ADCT) Deferred Taxes: 2022-2023
Historic Deferred Taxes for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2023 value amounting to $42.9 million.
- ADC Therapeutics' Deferred Taxes rose 2756.05% to $42.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $37.1 million, marking a year-over-year increase of 2388.96%. This contributed to the annual value of $37.1 million for FY2023, which is 2388.96% up from last year.
- Per ADC Therapeutics' latest filing, its Deferred Taxes stood at $42.9 million for Q4 2023, which was up 7,514.19% from -$578,000 recorded in Q3 2023.
- ADC Therapeutics' Deferred Taxes' 5-year high stood at $42.9 million during Q4 2023, with a 5-year trough of -$5.1 million in Q2 2023.
- Its 2-year average for Deferred Taxes is $4.4 million, with a median of -$36,568 in 2022.
- Examining YoY changes over the last 5 years, ADC Therapeutics' Deferred Taxes showed a top increase of 2,756.05% in 2023 and a maximum decrease of 131,165.76% in 2023.
- ADC Therapeutics' Deferred Taxes (Quarterly) stood at -$1.6 million in 2022, then soared by 2,756.05% to $42.9 million in 2023.
- Its Deferred Taxes was $42.9 million in Q4 2023, compared to -$578,000 in Q3 2023 and -$5.1 million in Q2 2023.